Virica is a cell enhancer company dedicated to improving manufacturing productivity and reducing production costs of cell and gene therapies (CGTs) and vaccines. Virica’s Viral Sensitizers (VSE™) are small-molecule media additives that temporarily dampen host-cell defenses, enhancing viral yields and improving vector quality and transduction efficiency across diverse manufacturing platforms. Beyond supplying VSEs as off-the-shelf reagents, Virica operates as a fast-turnaround service partner: our proprietary High-Throughput Virology (HTV™) platform, Design-of-Experiments (DoE) process optimization, and analytical testing workflows let developers rapidly pinpoint the best transfection or transduction conditions so programs can move to scale sooner and at lower cost.